Dr. Lal Path Labs
LALPATHLAB
Dr. Lal Path Labs Market Sentiment
| Timeline | Returns | Volume |
|---|---|---|
| Daily | - | 78,211 |
| Weekly | 1.58% | 14,38,534 |
| Monthly | 10.15% | 45,42,465 |
Dr. Lal Path Labs Performance
| Timeline | Daily | Weekly | Monthly |
|---|---|---|---|
| LALPATHLAB | - | 1.58% | 10.15% |
| Index | - | - | - |
| Peer Avg. | - | 6.39% | 7.71% |
Dr. Lal Path Labs Fundamentals
| Timeline | PE | PB | EV/EBIDTA | ROE | ROCE | Div. Yield |
|---|---|---|---|---|---|---|
| LALPATHLAB | 63.09 | 15.15 | 33.45 | 26.45 | 32.36 | 0.55 |
| Index | 35.44 | 5.98 | 16.81 | 16.99 | 18.41 | 1.19 |
| Peer Avg. | 61.02 | 8.64 | 23.72 | 18.31 | 22.63 | 0.52 |
Dr. Lal Path Labs Key Metrics
| Metrics | Sales Growth | Profit Growth | ROE | ROCE |
|---|---|---|---|---|
| FY '21-22 | 28.82% | 20.49% | 26.45% | 32.36% |
| FY '20-21 | 17.95% | 27.89% | 26.41% | 35.43% |
| FY '19-20 | 9.94% | 13.86% | 23.70% | 32.77% |
Dr. Lal Path Labs Shareholding Pattern
Dr. Lal Path Labs Profit & Loss
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| FY '21-22 | 1,980.06 | 1,444.59 | 588.25 | 347.17 |
| FY '20-21 | 1,535.91 | 1,114.08 | 473.13 | 288.29 |
| FY '19-20 | 1,301.98 | 966.28 | 392.02 | 225.38 |
Dr. Lal Path Labs Peer Comparison
| Metrics | Sales | Expenditure | EBITDA | PAT |
|---|---|---|---|---|
| LALPATHLAB | 1,980.06 | 1,444.59 | 588.25 | 347.17 |
| NH | 3,056.65 | 2,593.43 | 533.70 | 242.12 |
| FORTIS | 3,290.11 | 2,697.93 | 672.90 | 376.27 |
Dr. Lal Path Labs Share Price
Dr. Lal PathLabs Limited is an Indian company providing diagnostic and related healthcare tests and services. The company's activities include management of biochemistry, haematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology and other pathological and radiological research laboratories. It offers a variety of condition-based tests, including allergies, diabetes, health checks, viral infections, fever, heart disease, hypertension, cancer, miscarriages, anaemia, arthritis, breast cancer, diphtheria, liver disease, bone disease, abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscle disorders and viral infections. The company's subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited and Dr. Lal PathLabs Nepal Private Limited.